Zimbabwe has declined a major American health deal worth $367m (£272m) over five years due to the United States' insistence on sensitive information.
This rejection became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson later clarified that the United States was requesting biological samples for scientific study and commercial gain while was unwilling to guarantee the resulting advantages from any future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further negotiations to find a agreement suitable to all parties so the country's vital HIV programme can proceed.
Broader Context
This development follows a similar case in Kenya, where a court halted a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on statements, Sixteen African countries have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for medical research with no assurance that the final treatments would be available to our population if a new disease outbreak emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were undermining structures previously established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is designed to ensure that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations need to persist since much of the country's HIV programmes depended on international support.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.
The halted deal underscores the continuing challenges between receiving crucial foreign assistance and safeguarding local interests in an ever more interconnected world.